So I used to be into investing and I would look at small cap stocks, sometimes penny stocks or $5 stock. And it was critical for you to look at who was evaluating it. Of course, the company is going to come out with their own statements, but you know, an objective opinion. And when it comes to biotech, there's a lot of stuff out there. That's why you turn to a man like my next guest, John Vandermosten, he is a Biotech Analyst.